BERLIN (AP) – A senior German health official on Friday regretted that some neighboring countries had stopped using the AstraZeneca coronavirus vaccine after reports of blood clots in some people, despite the lack of evidence.
Health Minister Jens Span said that although Germany was reporting “very, very serious” possible side effects from the vaccine, the European Medicines Agency and the German Vaccine Authority said they had no evidence of dangerous blood clots. :
“I regret that, based on the information received on Friday morning, some EU countries have stopped vaccinating against AstraZeneca,” Span told reporters in Berlin.
Denmark was the first to temporarily suspend the AstraZeneca vaccine on Thursday following reports of blood clots in some people. The Scandinavian National Health Authority said the decision was made “on the precautionary principle” that one person who developed a blood clot after vaccination died.
Norway decided to pursue him and discontinued the Anglo-Swedish vaccine, which had been developed with Oxford University. The Italian pharmaceutical agency on Thursday ordered a warning ban on certain batches of the vaccine after saying it was a “serious adverse event”.
The European Medicines Agency, which has confirmed the shooting in 27 countries in the EU, Iceland, Liechtenstein and Norway, said that “the benefits of the vaccine continue to outweigh the risks, the vaccine can continue to be administered”, while close blood counts continue for thrombosis.
“Currently, there is no indication that the vaccine caused these conditions,” the regulator said. It says that the number of people who have been vaccinated with blood clots does not exceed those who have not been vaccinated.
The German health minister said there was no evidence of blood transfusions, adding that “a balance could be struck between being vigilant and not being alarmed”.
Other health experts say that people who are more likely to be vaccinated against COVID-19 are also more likely to have other health problems, which may put them at greater risk for developing blood clots.
The British drug regulator has said it has not received any reports of blood clots in humans from the AstraZeneca vaccine. More than 11 million doses of AstraZeneca have been used in the UK
“Reports of blood tissue received so far are not large enough to occur naturally among the vaccinated population,” the agency said. “People still have to go and get their COVID-19 vaccine when they ask for it.”
Follow AP epidemic coverage https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine և https://apnews.com/Und UndingingtheOutbreak.